First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Teladoc Health, Inc.

    TDOC · 4 developments mapped · last assessed 2026-09-25

    Market Ontology has mapped 4 macro, policy, and market developments to Teladoc Health, Inc. since 2026-09-01. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for TDOC yet, so no modelled value is shown. The TDOC valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run TDOC on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for TDOC. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      NexLife Launches Flat-Rate $119-$169 Compounded GLP-1 Programs Across Doses

      Increased demand for telehealth services to access and manage GLP-1 prescriptions, particularly for lower-cost compounded options that often rely on virtual care models.

      · Moves subscriber growth, utilization rates of virtual care services, average revenue per user (arpu)

    • Open question

      NexLife Expands Compounded GLP-1 Plans With Flat $119-$169 Monthly Tiers

      Increased competition in the telehealth-enabled GLP-1 weight management space, potentially impacting pricing or market share for existing programs, but also validating the telehealth model for GLP-1s.

      · Moves growth rate of chronic care programs, customer acquisition costs

    What changed, by assumption

    Subscriber growth
    • 2026-09-01NexLife Launches Flat-Rate $119-$169 Compounded GLP-1 Programs Across Doses
    Member growth
    • 2026-09-01NexLife Expands Compounded GLP-1 Pricing at $119-$169 Flat Monthly Fee
    Growth rate of chronic care programs
    • 2026-09-01NexLife Expands Compounded GLP-1 Plans With Flat $119-$169 Monthly Tiers
    Management stability
    • 2026-09-25Teladoc Health, Inc. Announces Resignation of Chief Legal Officer Adam C. Vandervoort

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-25Teladoc Health, Inc. Announces Resignation of Chief Legal Officer Adam C. Vandervoortwatch1-3m0.20
    2026-09-01NexLife Expands Compounded GLP-1 Pricing at $119-$169 Flat Monthly FeeBullish1-3m0.60
    2026-09-01NexLife Expands Compounded GLP-1 Plans With Flat $119-$169 Monthly Tiersmixed3-12m0.40
    2026-09-01NexLife Launches Flat-Rate $119-$169 Compounded GLP-1 Programs Across DosesBullish1-3m0.70